Atlas Trials

Selegiline for the Treatment of Excessive Daytime Sleepiness in Parkinson's Disease

Clinical trial NCT04870372 · COMPLETED

Trial details

NCT number
NCT04870372
Sponsor
Second Affiliated Hospital of Soochow University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Parkinson Disease
Start date
2020-03-01
Primary completion
2020-12-31
Enrollment
141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.